from ZeroHedge today "..both Bloomberg and Stat
Post# of 148169
(Total Views: 604)
Posted On: 08/23/2020 3:39:10 PM
from ZeroHedge today
"..both Bloomberg and StatNews report that Trump will announce that a new coronavirus treatment involving blood plasma from patients who have recovered from the disease, has received an emergency use authorization from the FDA, which is expected to clear for use with certain patients what’s known as convalescent plasma. The move, Bloomberg notes, would make it easier for patients to get the product, which Trump has touted even though its effectiveness hasn’t been proved.
"Trump's decision to forge ahead is predicated by a study conducted by the Mayo Clinic and the National Institutes of Health which found that plasma treatments appeared to have a small but statistically significant impact on reducing mortality in hospitalized Covid-19 patients who received the infusions within three days of the onset of symptoms, compared with those who got plasma later.
" Statnews notes that the decision, which Trump’s press secretary heralded ahead of time as a “major therapeutic breakthrough," likely falls far short of that description, "
"Sadly we still don't convincing RCT data that demonstrate its effectiveness after >5M cases in US...
https://www.zerohedge.com/political/trump-jab...ine-trials
"..both Bloomberg and StatNews report that Trump will announce that a new coronavirus treatment involving blood plasma from patients who have recovered from the disease, has received an emergency use authorization from the FDA, which is expected to clear for use with certain patients what’s known as convalescent plasma. The move, Bloomberg notes, would make it easier for patients to get the product, which Trump has touted even though its effectiveness hasn’t been proved.
"Trump's decision to forge ahead is predicated by a study conducted by the Mayo Clinic and the National Institutes of Health which found that plasma treatments appeared to have a small but statistically significant impact on reducing mortality in hospitalized Covid-19 patients who received the infusions within three days of the onset of symptoms, compared with those who got plasma later.
" Statnews notes that the decision, which Trump’s press secretary heralded ahead of time as a “major therapeutic breakthrough," likely falls far short of that description, "
"Sadly we still don't convincing RCT data that demonstrate its effectiveness after >5M cases in US...
https://www.zerohedge.com/political/trump-jab...ine-trials
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼